Modulate Bio
MA - AllstonBiotechnology
Focus: Modulate Bio is a public biotechnology company headquartered in Boston focused on neuromedicines with oncology therapeutic applications. The company operates at the intersection of neuroscience and oncology, though limited public information constrains detailed market positioning.
Profile data last refreshed 31m ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
5-1 this month
Stable — net -1 jobs in 30d
3 added, 4 removed. Backfill posture.
Should You Work at Modulate Bio?
AI assessmentEarly-stage or dormant public biotech with neuromedicines focus; pursue only if seeking deep research roles in undisclosed programs or if organizational reset is underway.
Why Work Here
- Public company status provides equity upside potential and institutional stability compared to private-stage biotech
- Specialized focus on neuromedicines in oncology targets an underexploited therapeutic intersection with high clinical value
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Modulate Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.